{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:13Z","timestamp":1793731033789,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07456-5","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:25:24Z","timestamp":1765038324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A\/THEM4 regulates progression phenotypes and mitophagy in vivo and in vitro"],"prefix":"10.1186","volume":"24","author":[{"given":"Gang","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"7456_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"Cancer J Clin"},{"key":"7456_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"key":"7456_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.027.","journal-title":"Cancer Lett"},{"key":"7456_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014.","journal-title":"Cell"},{"key":"7456_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-018-0817-x","volume":"17","author":"R Zhao","year":"2018","unstructured":"Zhao R, et al. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer. Mol Cancer. 2018;17:68. https:\/\/doi.org\/10.1186\/s12943-018-0817-x.","journal-title":"Mol Cancer"},{"key":"7456_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang M, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19:130. https:\/\/doi.org\/10.1186\/s12943-020-01249-8.","journal-title":"Mol Cancer"},{"key":"7456_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","volume":"30","author":"MC De Santis","year":"2024","unstructured":"De Santis MC, Bockorny B, Hirsch E, Cappello P, Martini M. Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends Mol Med. 2024;30:592\u2013604. https:\/\/doi.org\/10.1016\/j.molmed.2024.03.008.","journal-title":"Trends Mol Med"},{"key":"7456_CR8","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.Ccr-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res. 2018;24:2482\u201390. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-3070.","journal-title":"Clin Cancer Res"},{"key":"7456_CR9","first-page":"992","volume":"13","author":"PP Ding","year":"2023","unstructured":"Ding PP, et al. PTPMT1 regulates mitochondrial death through the SLC25A6-NDUFS2 axis in pancreatic cancer cells. Am J Cancer Res. 2023;13:992\u20131003.","journal-title":"Am J Cancer Res"},{"key":"7456_CR10","doi-asserted-by":"publisher","first-page":"e2207349","DOI":"10.1002\/advs.202207349","volume":"10","author":"M Wei","year":"2023","unstructured":"Wei M, et al. YY2-DRP1 axis regulates mitochondrial fission and determines cancer stem cell asymmetric division. Adv Sci (Weinh). 2023;10:e2207349. https:\/\/doi.org\/10.1002\/advs.202207349.","journal-title":"Adv Sci (Weinh)"},{"key":"7456_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5.","journal-title":"Lancet"},{"key":"7456_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/annonc\/mdw040","volume":"27","author":"NY Chia","year":"2016","unstructured":"Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27:763\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdw040.","journal-title":"Ann Oncol"},{"key":"7456_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, et al. 70-Gene signature as an aid to treatment decisions in Early-Stage breast cancer. N Engl J Med. 2016;375:717\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1602253.","journal-title":"N Engl J Med"},{"key":"7456_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2217\/fon-2018-0221","volume":"15","author":"M Brand\u00e3o","year":"2019","unstructured":"Brand\u00e3o M, Pond\u00e9 N, Piccart-Gebhart M. Mammaprint\u2122: a comprehensive review. Future Oncol. 2019;15:207\u201324. https:\/\/doi.org\/10.2217\/fon-2018-0221.","journal-title":"Future Oncol"},{"key":"7456_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejca.2021.06.032","volume":"154","author":"MG Davey","year":"2021","unstructured":"Davey MG, Richard V, Lowery AJ, Kerin MJ. OncotypeDX\u00a9 recurrence score in BRCA mutation carriers: a systematic review and meta-analysis. Eur J Cancer. 2021;154:209\u201316. https:\/\/doi.org\/10.1016\/j.ejca.2021.06.032.","journal-title":"Eur J Cancer"},{"key":"7456_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s10495-023-01843-3","volume":"28","author":"HF Yao","year":"2023","unstructured":"Yao HF, et al. Analysis of cuproptosis-related LncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer. Apoptosis. 2023;28:1090\u2013112. https:\/\/doi.org\/10.1007\/s10495-023-01843-3.","journal-title":"Apoptosis"},{"key":"7456_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12967-024-05158-y","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with Endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer. J Translational Med. 2024;22:393. https:\/\/doi.org\/10.1186\/s12967-024-05158-y.","journal-title":"J Translational Med"},{"key":"7456_CR18","doi-asserted-by":"publisher","first-page":"561254","DOI":"10.3389\/fgene.2021.561254","volume":"12","author":"J Huo","year":"2021","unstructured":"Huo J, Wu L, Zang Y. Development and validation of a novel Metabolic-Related signature predicting overall survival for pancreatic cancer. Front Genet. 2021;12:561254. https:\/\/doi.org\/10.3389\/fgene.2021.561254.","journal-title":"Front Genet"},{"key":"7456_CR19","doi-asserted-by":"publisher","unstructured":"Tian X, et al. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.939542.","DOI":"10.3389\/fphar.2022.939542"},{"key":"7456_CR20","doi-asserted-by":"publisher","first-page":"702102","DOI":"10.3389\/fgene.2021.702102","volume":"12","author":"M Mao","year":"2021","unstructured":"Mao M, et al. Construction and validation of an Immune-Based prognostic model for pancreatic adenocarcinoma based on public databases. Front Genet. 2021;12:702102. https:\/\/doi.org\/10.3389\/fgene.2021.702102.","journal-title":"Front Genet"},{"key":"7456_CR21","doi-asserted-by":"publisher","unstructured":"Xu Y, et al. Cuprotosis-related genes: predicting prognosis and immunotherapy sensitivity in pancreatic cancer patients. J Oncol. 2022;2022(2363043). https:\/\/doi.org\/10.1155\/2022\/2363043.","DOI":"10.1155\/2022\/2363043"},{"key":"7456_CR22","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1016\/j.csbj.2022.07.030","volume":"20","author":"L Tang","year":"2022","unstructured":"Tang L, et al. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Comput Struct Biotechnol J. 2022;20:4402\u201314. https:\/\/doi.org\/10.1016\/j.csbj.2022.07.030.","journal-title":"Comput Struct Biotechnol J"},{"key":"7456_CR23","doi-asserted-by":"publisher","first-page":"145804","DOI":"10.1016\/j.gene.2021.145804","volume":"795","author":"F Xu","year":"2021","unstructured":"Xu F, et al. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma. Gene. 2021;795:145804. https:\/\/doi.org\/10.1016\/j.gene.2021.145804.","journal-title":"Gene"},{"key":"7456_CR24","doi-asserted-by":"publisher","first-page":"105370","DOI":"10.1016\/j.phrs.2020.105370","volume":"164","author":"D Xu","year":"2021","unstructured":"Xu D, et al. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. Pharmacol Res. 2021;164:105370. https:\/\/doi.org\/10.1016\/j.phrs.2020.105370.","journal-title":"Pharmacol Res"},{"key":"7456_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"key":"7456_CR26","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.Can-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83:3861\u20137. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0816.","journal-title":"Cancer Res"},{"key":"7456_CR27","doi-asserted-by":"publisher","first-page":"e1000307","DOI":"10.1371\/journal.pmed.1000307","volume":"7","author":"JK Stratford","year":"2010","unstructured":"Stratford JK, et al. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 2010;7:e1000307. https:\/\/doi.org\/10.1371\/journal.pmed.1000307.","journal-title":"PLoS Med"},{"key":"7456_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1.","journal-title":"Genome Biol"},{"key":"7456_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"7456_CR30","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"key":"7456_CR31","doi-asserted-by":"publisher","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.26476.","DOI":"10.7554\/eLife.26476"},{"key":"7456_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, et al. Molecular and Pharmacological modulators of the tumor immune contexture revealed by Deconvolution of RNA-seq data. Genome Med. 2019;11:34. https:\/\/doi.org\/10.1186\/s13073-019-0638-6.","journal-title":"Genome Med"},{"key":"7456_CR33","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"7456_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"7456_CR35","doi-asserted-by":"publisher","first-page":"803962","DOI":"10.3389\/fimmu.2022.803962","volume":"13","author":"M Xiao","year":"2022","unstructured":"Xiao M, et al. A DNA-Methylation-Driven genes based prognostic signature reveals immune microenvironment in pancreatic cancer. Front Immunol. 2022;13:803962. https:\/\/doi.org\/10.3389\/fimmu.2022.803962.","journal-title":"Front Immunol"},{"key":"7456_CR36","doi-asserted-by":"publisher","first-page":"1022420","DOI":"10.3389\/fimmu.2022.1022420","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, et al. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis. Front Immunol. 2022;13:1022420. https:\/\/doi.org\/10.3389\/fimmu.2022.1022420.","journal-title":"Front Immunol"},{"key":"7456_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-021-01389-5","volume":"20","author":"F Jin","year":"2021","unstructured":"Jin F, et al. A novel class of TsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer. Mol Cancer. 2021;20:95. https:\/\/doi.org\/10.1186\/s12943-021-01389-5.","journal-title":"Mol Cancer"},{"key":"7456_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41419-020-2553-6","volume":"11","author":"SQ Wang","year":"2020","unstructured":"Wang SQ, et al. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation. Cell Death Dis. 2020;11:410. https:\/\/doi.org\/10.1038\/s41419-020-2553-6.","journal-title":"Cell Death Dis"},{"key":"7456_CR39","doi-asserted-by":"publisher","unstructured":"Xavier AET, et al. Low PRKAB2 expression is associated with poor outcomes in pediatric adrenocortical tumors, and treatment with Rottlerin increases the PRKAB2 level and inhibits tumorigenic aspects in the NCI-H295R adrenocortical cancer cell line. Cancers (Basel). 2024;16. https:\/\/doi.org\/10.3390\/cancers16061094.","DOI":"10.3390\/cancers16061094"},{"key":"7456_CR40","doi-asserted-by":"publisher","first-page":"672684","DOI":"10.3389\/fonc.2021.672684","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang S, et al. Exosomal miR-183-5p shuttled by M2 polarized Tumor-Associated macrophage promotes the development of colon cancer via targeting THEM4 mediated PI3K\/AKT and NF-\u03baB pathways. Front Oncol. 2021;11:672684. https:\/\/doi.org\/10.3389\/fonc.2021.672684.","journal-title":"Front Oncol"},{"key":"7456_CR41","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.Can-21-0747","volume":"81","author":"T-J Yu","year":"2021","unstructured":"Yu T-J, et al. PDSS1-Mediated activation of CAMK2A-STAT3 signaling promotes metastasis in Triple-Negative breast cancer. Cancer Res. 2021;81:5491\u2013505. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0747.","journal-title":"Cancer Res"},{"key":"7456_CR42","doi-asserted-by":"publisher","unstructured":"Xue R et al. Mitofusin2 induces cell autophagy of pancreatic cancer through inhibiting the PI3K\/Akt\/mTOR signaling pathway. Oxid Med Cell Longev 2018, 2798070. https:\/\/doi.org\/10.1155\/2018\/2798070.","DOI":"10.1155\/2018\/2798070"},{"key":"7456_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"7456_CR44","doi-asserted-by":"publisher","unstructured":"Rafaeva M, et al. Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1154528.","DOI":"10.3389\/fimmu.2023.1154528"},{"key":"7456_CR45","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3748\/wjg.v30.i19.2575","volume":"30","author":"T Peng","year":"2024","unstructured":"Peng T, et al. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. World J Gastroenterol. 2024;30:2575\u2013602. https:\/\/doi.org\/10.3748\/wjg.v30.i19.2575.","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07456-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07456-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07456-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:05:26Z","timestamp":1768341926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07456-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7456"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07456-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients who underwent surgery at Changhai Hospital were enrolled. Written informed consent was obtained from all patients involved in this study, which was approved by the Ethics Committee of Changhai Hospital. And this study followed the guidelines outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"All authors consent for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}